In breast cancer, post-diagnosis miRNA levels have been shown to correlate with a number of tumor characteristics, including stage, vascular invasion, proliferative index, and estrogen receptor/progesterone receptor (ER/PR) status [9,10], and may have prognostic value. This evidence concerns the gene ESR1 and breast carcinoma.